Airway Occlusion Pressure (P0.1) Guided Pressure Support Ventilation Versus Conventional Management in Weaning Window Patients
Airway Occlusion Pressure (P0.1) Guided Pressure Support Ventilation Versus Conventional Management in Weaning Window Patients: A Randomized Controlled Trial
研究概览
地位
详细说明
Mechanical ventilation is an essential modality for critically ill patients with acute respiratory failure. It supports gas exchange and reduces respiratory muscle workload, but prolonged use increases the risk of lung injury, diaphragm dysfunction, and infection. Therefore, the process of ventilator weaning is crucial in optimizing patient outcomes.
Airway occlusion pressure (P0.1), the negative pressure generated 100 ms after the onset of inspiration during an occluded breath, provides a direct measurement of patient respiratory drive independent of lung mechanics. It is a strong indicator of ventilatory demand and drive-load imbalance.
Pressure Support Ventilation (PSV) is commonly used during the weaning window, but conventional titration methods rely on clinical assessment alone. These methods do not reliably identify asynchronous events such as ineffective effort, double triggering, or premature cycling, which prolong ventilation.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Muhammad A Kandil, MSc
- 电话号码:00201022644722
- 邮箱:muhammad.kandil@med.tanta.edu.eg
学习地点
-
-
Al Gharbia
-
Tanta、Al Gharbia、埃及、31527
- 招聘中
- Tanta University
-
副研究员:
- Aliaa M Belal, MD
-
副研究员:
- Taysser M Abdalraheem, MD
-
副研究员:
- Sohair M Soliman, MD
-
接触:
- Muhammad A Kandil, MSc
- 电话号码:00201022644722
- 邮箱:muhammad.kandil@med.tanta.edu.eg
-
副研究员:
- Ghada F Elbaradey, MD
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Mechanically ventilated adult patients ≥ 21 years.
- Patients on pressure support ventilation for at least 24 hours and clinically determined to be in the weaning window (transition between assisted ventilation and spontaneous ventilation) with improving respiratory status.
- Hemodynamically stable [mean arterial pressure (MAP) ≥60 mmHg].
- All patients will be required to have light sedation with a Richmond Agitation-Sedation Scale (RASS) score between -1 and 0 to allow reliable assessment of respiratory drive.
Exclusion Criteria:
- Patients with neuromuscular disorders affecting respiratory drive
- Glasgow Coma Scale (GCS) score below 8
- Cervical spinal cord injury
- Receipt of neuromuscular blockers within the previous 24 hours
- Morbid obesity resulting in unreliable respiratory mechanics
- Pregnancy
- Deep sedation defined as RASS ≤ -2
- Hemodynamic instability requiring escalating vasopressor support.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Group I (Control Group)
Patients will receive a conventional pressure support ventilation protocol.
|
Patients will receive a conventional pressure support ventilation protocol.
|
|
实验性的:Group II (Study Group)
Patients will receive airway occlusion pressure (P0.1)-guided pressure support ventilation (PSV).
|
Patients will receive airway occlusion pressure (P0.1)-guided pressure support ventilation (PSV).
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Ventilator-Free Days
大体时间:Day 28 after the procedure
|
Ventilator-Free Days (VFD) at Day 28, defined as the number of days a patient is free from mechanical ventilation within the first 28 days after randomization.
VFD are calculated as 28 minus the total days on mechanical ventilation from Day 0 until successful extubation.
|
Day 28 after the procedure
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Duration of Mechanical Ventilation
大体时间:Till final successful extubation (Up to 48 hours)
|
Duration of Mechanical Ventilation (DMV) is defined as the total days on mechanical ventilation (MV) from randomization until final successful extubation.
|
Till final successful extubation (Up to 48 hours)
|
|
Length of stay in the intensive care unit
大体时间:Till the discharge from intensive care unit (Up to 28 days)
|
The length of stay in the intensive care unit (ICU) will be recorded from ICU admission to ICU discharge.
|
Till the discharge from intensive care unit (Up to 28 days)
|
|
Patient-Ventilator Asynchrony Index (PVAI)
大体时间:Day 28 after the procedure
|
Daily analysis of a 10-minute waveform segment.
"PVAI"="Asynchronous events" /"Total breaths" ×100
|
Day 28 after the procedure
|
|
Dexmedetomidine requirement
大体时间:Day 28 after the procedure
|
Total dose of dexmedetomidine administered to maintain the target sedation level of Richmond Agitation-Sedation Scale (RASS) -1 to 0 during the weaning period.
|
Day 28 after the procedure
|
|
Failed weaning
大体时间:48 hours after extubation
|
"Failed weaning" is defined as reintubation within 48 hours after extubation.
|
48 hours after extubation
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 36265MD41027/1/6
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.